Inside Innovation

Following its acquisition of Seattle-based Seagen, Pfizer has systemically laid out its new oncology strategy and aims to have at least eight blockbuster cancer drugs by

AstraZeneca announced the closing of a $1.1 billion acquisition deal of Icosavax, a Seattle-based biopharmaceutical company. Icosavax’s brand will be absorbed into the larger company

The University of Washington’s (UW) tech transfer office, CoMotion, has facilitated the creation of seven startups since July of last year. These companies, all in

Sana Biotechnology, based in Seattle, published preclinical data demonstrating the company successfully controlled glucose levels in a diabetic primate through genetically engineered pancreatic islet cells.

ProfoundBio, a Seattle-based biotech company on a mission to redefine cancer treatment, announced a $112 million Series B round. According to Erin Lavelle, chief operating

Jubilant HollisterStier, a Spokane-based integrated contract manufacturer, has opened its third sterile fill finish manufacturing line and broken ground for the next phase of the

Life Science Washington released its Life Science News in the NW newsletter for Q4 2023, revealing key industry developments in Washington state. While many industries

Washington state saw considerable growth in Milken Institute’s 2024 Best Performing Cities ranking, with Seattle moving from spot 34 to 24 and the Olympia-Tumwater metro

A prototype for a temperature-sensitive earring has been created by researchers at University of Washington. Coined the “Thermal Earring,” the wireless jewelry includes a sensor

Seattle-based biotech company Proniras raised $4.65 million in a recent Series B funding round to support its tezampanel, an opiate withdrawal therapy and Proniras’ leading

Kayla Young, chief operating officer at Seattle-based life science company Phase Genomics, discusses her experience in Washington’s life sciences and offers insights to other employees

Seattle-based life science company Lundbeck Therapeutics is prioritizing its long-term growth efforts, with recently hired CEO Charl van Zyl looking to facilitate strategic and systematic